Scancell Holdings Plc

33
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00B63D3314
GBP
0.12
-0.01 (-7.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Scancell Holdings Plc Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Apr'25
Apr'24
Apr'23
Apr'22
Apr'21
Apr'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-15.00
-9.00
-14.00
-6.00
-16.00
-6.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-6.00
-15.00
-8.00
-10.00
-7.00
-4.00
Cash Flow from Investing Activities
-1.00
0.00
0.00
-1.00
0.00
0.00
Cash Flow from Financing Activities
9.00
10.00
0.00
0.00
46.00
3.00
Net Cash Inflow / Outflow
2.00
-5.00
-8.00
-12.00
37.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in GBP Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Scancell Holdings Plc
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(GBP)
Change(%)
Profit Before Tax
-15.303
-47.265
32.00
67.62%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.732
-34.383
34.00
102.13%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-6.106
-50.628
44.00
87.94%
Cash Flow from Investing Activities
-1.539
1.508
-2.00
-202.06%
Cash Flow from Financing Activities
9.733
6.994
3.00
39.16%
Net Cash Inflow / Outflow
2.077
-43.066
45.00
104.82%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.011
-0.94
0.00
98.83%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Apr'25
stock-summary

YoY Growth in year ended Apr 2025 is 61.60% vs -89.44% in Apr 2024

Apr'25
Apr'24
Change(%)
Cash Flow from Operating Activities
-6.11
-15.90
61.60%